Teva Pharmaceuticals USA Recall: MethylPREDNISolone Acetate Injectable Suspension USP 400
Teva Pharmaceuticals USA Recall: MethylPREDNISolone Acetate Injectable Suspension USP 400 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA; Product: MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Ma
| Recalling firm | Teva Pharmaceuticals USA |
|---|---|
| Product | MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons. |
| Reason for recall | Lack of Assurance of Sterility |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Methylprednisolone, TN Norepinephrine BItartrate - MS, OH |
| Recall initiated | 20211231 |
| Recall number | D-0370-2022 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →